Avior Wealth Management’s Praxis Precision Medicines PRAX Stock Holding History

Avior Wealth Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$227K	Buy	+780	New	+$258K	0.01%	731

Other funds holding PRAX

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Net Worth Advisory Group Sandy, Utah $397M AUM 23.64% 1-Year Est. Return

Eagle Bay Advisors New York $137M AUM 18.51% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Avior Wealth Management's PRAX Position: Q3 2026 in Review

Avior Wealth Management opened a new position in Praxis Precision Medicines (PRAX) in Q3 2026: 780 shares worth $227K. The stake represents 0.01% of the portfolio and ranks #731 among its holdings.

21 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

Avior Wealth Management held 780 shares of Praxis Precision Medicines worth $227K as of Q3 2026.
Praxis Precision Medicines was a new Avior Wealth Management position in Q3 2026.
Praxis Precision Medicines made up 0.01% of Avior Wealth Management's portfolio in Q3 2026, its #731 holding.
21 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Avior Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.